This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

JAMA. 2002;288:157-158.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2002;51:501-502

Persons with advanced human immunodeficiency virus (HIV)-1 infection are susceptible to disseminated mycobacterial infections. In the United States, most such infections are caused by Mycobacterium avium or M. intracellulare (i.e., M. avium complex [MAC]). In less developed countries, M. tuberculosis is equally or more prevalent than MAC in persons with HIV-1 infection.¹ Other mycobacterial species have been reported to cause disseminated infection in HIV-infected persons, including Simiae-Avium (SAV) group mycobacteria. SAV group organisms share characteristics of M. avium and M. simiae.² Although disseminated (i.e., the isolation of a mycobacterial species from the blood) infection with M. simiae has been reported in HIV-infected persons,^3-6 another distinct species within the SAV group, M. triplex, was characterized in 1996.⁷ Two cases of disseminated infection caused by M. triplex have been reported in HIV-1-positive persons.^8-9 This report describes four HIV-infected patients from Bangkok, Thailand, and Lilongwe, Malawi, who were infected . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical relevance of Mycobacterium simiae in pulmonary samples
van Ingen et al.
Eur Respir J 2008;31:106-109.
ABSTRACT | FULL TEXT